Matches in Nanopublications for { ?s ?p "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- NP334098.RAQ6LiL3NaFiTZuRraEcmQSY18CJwsBFByXW80joC3uZs130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334098.RAQ6LiL3NaFiTZuRraEcmQSY18CJwsBFByXW80joC3uZs130_provenance.
- NP393353.RARxEKdbgRf_SOrTKqrP4Fxt2cfciqU1UX-GQFhKm3lvA130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393353.RARxEKdbgRf_SOrTKqrP4Fxt2cfciqU1UX-GQFhKm3lvA130_provenance.
- NP678950.RAS-zk-H3d9dNxhXYdDLsCjgW5KyikM-lnkpvCyjvLsTk130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678950.RAS-zk-H3d9dNxhXYdDLsCjgW5KyikM-lnkpvCyjvLsTk130_provenance.
- assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_provenance.
- NP1083152.RAVcv68ldULRuy-ds7Pd_9npjIPq2xV6WoZy-yvAyKay4130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1083152.RAVcv68ldULRuy-ds7Pd_9npjIPq2xV6WoZy-yvAyKay4130_provenance.
- NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_provenance.
- NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_provenance.
- NP412044.RAvzrMNGwVoZezKLHEzR7ImDg-70_Qt2HUyRqTLdXb0cU130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412044.RAvzrMNGwVoZezKLHEzR7ImDg-70_Qt2HUyRqTLdXb0cU130_provenance.
- NP1083151.RAhv03e-h2ANjxt7lRBvjw-Y98u_dKFoNQVm0GJQnJVwA130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1083151.RAhv03e-h2ANjxt7lRBvjw-Y98u_dKFoNQVm0GJQnJVwA130_provenance.
- NP411707.RA-v24-nN-uRFaiW-UkqtOQGA85-xMbFA8LlFGaQIxRPY130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411707.RA-v24-nN-uRFaiW-UkqtOQGA85-xMbFA8LlFGaQIxRPY130_provenance.
- NP1083154.RAGhHZp8X8BEHV_5PqJaHsPMmmJijnfU4vs59KhqD1yOo130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1083154.RAGhHZp8X8BEHV_5PqJaHsPMmmJijnfU4vs59KhqD1yOo130_provenance.
- NP1083150.RA44gz_QT8BvnfZUp0uxJpZdGIImjM_acx_4BNLPNkwhs130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1083150.RA44gz_QT8BvnfZUp0uxJpZdGIImjM_acx_4BNLPNkwhs130_provenance.